US Stock Market Move | Tesla, Inc. (TSLA.US) rose by over 4% after launching a lower-priced version of the Model 3 in Hong Kong and Macau.
On Monday, Tesla (TSLA.US) rose more than 4%, reaching $364.85.
On Monday, Tesla, Inc. (TSLA.US) rose over 4%, closing at $364.85. In terms of news, Tesla, Inc. has officially launched a simplified version of the Model 3 at a lower price in Hong Kong and Macau. According to the Tesla, Inc. official website, the starting price for this model in Hong Kong is HKD 205,000 (approximately RMB 175,900), while in Macau, the starting price is MOP 252,000 (approximately RMB 209,800).
On September 3, Tesla, Inc. plans to unveil its driverless model Cybercab, which has no steering wheel and no pedals, in Austin; the model has already completed road testing and employee trials and will be opened to employees first, followed by the public.
Related Articles

HK Stock Market Move | INGDAN (00400.HK) surged more than 7% during trading, with mid-term revenue increasing by 98.4% and AI Token factory orders being realized.

HK Stock Market Move | JS GLOBAL LIFE (01691) rose over 6%, achieving a turnaround to profitability in the first half of the year, with the Ninja brand performing impressively.

HK Stock Market Move | TENNOR THERAP-B (06872) surged over 15% in morning trading. Positive proof-of-concept data from its Phase IIa trial of rifapentine. Phase IIb clinical trial approved and set to commence.
HK Stock Market Move | INGDAN (00400.HK) surged more than 7% during trading, with mid-term revenue increasing by 98.4% and AI Token factory orders being realized.

HK Stock Market Move | JS GLOBAL LIFE (01691) rose over 6%, achieving a turnaround to profitability in the first half of the year, with the Ninja brand performing impressively.

HK Stock Market Move | TENNOR THERAP-B (06872) surged over 15% in morning trading. Positive proof-of-concept data from its Phase IIa trial of rifapentine. Phase IIb clinical trial approved and set to commence.

RECOMMEND





